tyrosine kinase inhibitors tkis and antineoplastic anti cancer drugs

Cazonib (Cabozantinib Tablets) is an anti-cancer medication containing Cabozantinib, a targeted therapy used in the treatment of certain types of advanced cancers. Cabozantinib belongs to a class of medicines called tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins involved in cancer cell growth, spread, and the formation of new blood vessels that supply tumors. Active Ingredient: Cabozantinib Therapeutic Category: Targeted Cancer Therapy / Tyrosine Kinase Inhibitor Uses: Cazonib (Cabozantinib) is commonly prescribed for: Advanced Renal Cell Carcinoma (Kidney Cancer) Hepatocellular Carcinoma (Liver Cancer) after prior therapy in eligible patients Medullary Thyroid Cancer that has spread or cannot be treated with surgery How Cabozantinib Works: Cabozantinib blocks multiple receptor tyrosine kinases, including VEGFR, MET, and AXL pathways, which play important roles in tumor growth, cancer cell survival, and blood vessel formation. By inhibiting these pathways, it helps slow cancer progression. Available Strengths: Cabozantinib 20 mg Tablets Cabozantinib 40 mg Tablets Cabozantinib 60 mg Tablets Key Benefits: ✔ Targeted treatment approach for advanced cancers ✔ Helps slow tumor growth and progression ✔ Used in cancers where specific growth pathways are active Common Side Effects: Fatigue and weakness Diarrhea Loss of appetite Nausea or vomiting Mouth sores Weight loss Changes in taste Increased blood pressure Hand-foot skin reactions Important Information: Cazonib should be taken only under the supervision of an oncologist or qualified healthcare professional. Dose adjustments may be required depending on tolerance and medical condition. Regular monitoring of blood pressure, liver function, and overall health is recommended during